Share on StockTwits

Molina Healthcare (NYSE:MOH) has received a consensus rating of “Buy” from the fifteen analysts that are presently covering the company, American Banking News reports. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $47.23.

Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Molina Healthcare from a “neutral” rating to an “outperform” rating in a research note on Thursday. They now have a $55.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Molina Healthcare in a research note on Thursday. They now have a $54.00 price target on the stock, up previously from $47.00. Finally, analysts at Leerink Swann raised their price target on shares of Molina Healthcare from $40.00 to $45.00 in a research note on Monday, June 30th.

Molina Healthcare (NYSE:MOH) opened at 45.54 on Thursday. Molina Healthcare has a 52-week low of $31.10 and a 52-week high of $47.00. The stock has a 50-day moving average of $44.58 and a 200-day moving average of $38.9. The company has a market cap of $2.107 billion and a P/E ratio of 77.74.

Molina Healthcare (NYSE:MOH) last released its earnings data on Thursday, May 1st. The company reported $0.10 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.01) by $0.11. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.06 billion. During the same quarter in the prior year, the company posted $0.64 earnings per share. The company’s quarterly revenue was up 30.1% on a year-over-year basis. Analysts expect that Molina Healthcare will post $2.03 EPS for the current fiscal year.

Molina Healthcare, Inc provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.